Telomir Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Telomir Pharmaceuticals Inc share price today is $1.31, up 0%. The stock opened at $1.28 against the previous close of $1.32, with an intraday high of $1.32 and low of $1.28.

Telomir Pharmaceuticals Inc Share Price Chart

Telomir Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
us-stock

Telomir Pharmaceuticals Inc Share Price Performance

$1.31 0(0%) TELO at 23 Mar 2026 03:27 PM Biotechnology
Lowest Today 1.28
Highest Today 1.32
Today’s Open 1.28
Prev. Close 1.32
52 Week High 4.81
52 Week Low 1.05
Day’s Range: Low 1.28 High 1.32
52-Week Range: Low 1.05 High 4.81
1 day return -
1 Week return -1.48
1 month return +15.65
3 month return -6.33
6 month return -15.28
1 year return -70.31
3 year return -
5 year return -
10 year return -

Telomir Pharmaceuticals Inc Institutional Holdings

Telomir Pharmaceuticals Inc Market Status

Telomir Pharmaceuticals Inc Fundamentals

Market Cap 45.38 M

PB Ratio 6.5025

PE Ratio 0.0

Enterprise Value 45.14 M

Total Assets 7.34 M

Volume 97340

Telomir Pharmaceuticals Inc Company Financials

Annual Revenue FY24:0 0.0M, FY23:0 0.0M

Annual Profit FY24:null 0.0M, FY23:null 0.0M

Annual Net worth FY24:-16532716 -16.5M, FY23:-13071864 -13.1M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q4/2024:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q4/2024:null 0.0M, Q3/2024:-6006178 -6.0M

Quarterly Net worth Q3/2025:-1102294 -1.1M, Q2/2025:-5069890 -5.1M, Q1/2025:-2179828 -2.2M, Q4/2024:-2898373 -2.9M, Q3/2024:-5990733 -6.0M

About Telomir Pharmaceuticals Inc & investment objective

Company Information Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

Organisation Biotechnology

Employees 0

Industry Biotechnology

CEO Mr. Erez Aminov

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Telomir Pharmaceuticals Inc FAQs

What is the share price of Telomir Pharmaceuticals Inc today?

The current share price of Telomir Pharmaceuticals Inc is $1.31.

Can I buy Telomir Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy Telomir Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Telomir Pharmaceuticals Inc shares in India?

You can easily invest in Telomir Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of Telomir Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Telomir Pharmaceuticals Inc?

Telomir Pharmaceuticals Inc has a market cap of $45.38 M.

In which sector does Telomir Pharmaceuticals Inc belong?

Telomir Pharmaceuticals Inc operates in the Biotechnology sector.

What documents are required to invest in Telomir Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Telomir Pharmaceuticals Inc?

The PE ratio of Telomir Pharmaceuticals Inc is N/A and the PB ratio is 6.50.